Korean Govt Asks MNCs For More Hepatitis A Vaccines
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Alarmed by the rapidly rising demand for hepatitis A vaccines to treat students and office workers with the virus, South Korea's Center for Disease Control and Prevention is calling on four multinational companies to bring more vaccines to Korea
You may also be interested in...
Korea’s Bukwang To Sell Hepatitis B Drug In Philippines, Plans Launches In U.S., Europe
SEOUL - South Korea's Bukwang Pharmaceutical will begin selling its chronic hepatitis B drug Levovir (clevudine) in the Philippines in June, and plans to eventually launch the product across Asia, the U.S. and Europe, according to a company executive
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).